| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 65 |
| 1 | TREPROSTINIL | 57 |
| 2 | AMBRISENTAN | 46 |
| 3 | SILDENAFIL | 45 |
| 4 | MACITENTAN | 42 |
| 5 | ALBUTEROL SULFATE | 34 |
| 6 | TADALAFIL | 34 |
| 7 | 0XYGEN | 32 |
| 8 | ALBUTEROL | 32 |
| 9 | OXYGEN | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLEVIDIPINE | 25 | 0.0681 |
| 1 | OXYTOCIN | 24 | 0.0079 |
| 2 | LUSPATERCEPT | 12 | 0.0046 |
| 3 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 4 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | TOBRAMYCIN SULFATE | 23 | 0.0018 |
| 6 | TOBRAMYCIN SOLUTION | 20 | 0.0016 |
| 7 | EPOPROSTENOL | 17 | 0.0013 |
| 8 | FENOFIBRIC ACID | 1 | 0.0013 |
| 9 | SELEXIPAG | 31 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 88 |
| 1 | Prostacycline Vasodilator [EPC] | 67 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 61 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 49 |
| 4 | Loop Diuretic [EPC] | 37 |
| 5 | Proton Pump Inhibitor [EPC] | 33 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 31 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 26 |
| 8 | Oxytocic [EPC] | 24 |
| 9 | Calcium Channel Blocker [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 24 | 0.0079 |
| 1 | Erythroid Maturation Agent [EPC] | 12 | 0.0046 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 8 | 0.0018 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 31 | 0.0012 |
| 4 | Prostacycline Vasodilator [EPC] | 67 | 0.0005 |
| 5 | Anti-anginal [EPC] | 5 | 0.0005 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 61 | 0.0005 |
| 7 | Aminoglycoside Antibacterial [EPC] | 20 | 0.0004 |
| 8 | Endothelin Receptor Antagonist [EPC] | 88 | 0.0004 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 13 | 0.0004 |